Search clinical trials for: HS-10502

Total 296 results

HeadSense Medical

Suspended

An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device

Stroke | Brain Injuries | Brain Neoplasms | Intracranial Hypertension | Hydrocephalus

Japan
HeadSense Medical
Elisabeth-TweeSteden Ziekenhuis

Completed

Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring

Brain Injuries | Intracranial Hypertension

Netherlands
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

China
SpinChip Diagnostics ASA
University Hospital, Akershus; Scandinavian Contract Research Organization

Recruiting

SpinChip Hs-cTnI Sample Type Validation (HEAT-2)

Acute Myocardial Infarction

Norway
Baohui Han
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns (APPOINT)

Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Active, not recruiting

Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers

Healthy

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Nonsmall Cell Lung Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10380 in Chinese Participants

Schizophrenia

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection

Chronic HBV Infection

China
HeadSense Medical
Akron Children's Hospital

Unknown

Indirect Intracranial Pressure Measurement in Patients With Suspected or Documented Concussion

Brain Injuries | Brain Concussion

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers

Healthy
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

CML, Chronic Phase | CML, Accelerated Phase

China
Oslo University Hospital
University of Oslo

Completed

One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome (OUT-ACS)

Acute Coronary Syndrome | Angina, Unstable | NSTEMI - Non-ST Segment Elevation MI | Non-ST Elevation Myocardial Infarction

Norway
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

Non Small Cell Lung Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of HS-10360 in Healthy Subjects.

Healthy
EQRx International, Inc.

Completed

An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143

Severe Hepatic Impairment

United States
HeadSense Medical
University Medical Center Goettingen; Klinikum Darmstadt; Klinikum Stuttgart

Unknown

An Evaluation of a Non-invasive Brain Monitor

Brain Injuries | Brain Neoplasms | Subarachnoid Hemorrhage | Vasospasm, Intracranial | Hydrocephalus

Germany
HeadSense Medical
Akron Children's Hospital

Withdrawn

Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients

Intracranial Hypertension

United States
HeadSense Medical
Vanderbilt University Medical Center

Unknown

An Evaluation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion

Brain Injuries | Brain Concussion

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers

Healthy
Zhejiang Hisun Pharmaceutical Co. Ltd.
Covance

Completed

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

Primary Hypercholesterolemia

United States
Université de Sherbrooke

Completed

Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value? (TnT-HD)

Renal Failure

Canada
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

Diabetes Mellitus, Type 2

China
GWT-TUD GmbH

Terminated

Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia (August2)

Diabetic Foot | Critical Limb Ischemia

Germany
OliPass Australia Pty Ltd
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

Osteoarthritis

Australia
Hansoh BioMedical R&D Company

Not yet recruiting

A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer
University of Miami

Recruiting

Mindfulness Training Hidradenitis Suppurativa (HS)

Quality of Life | Hidradenitis Suppurativa

United States
Ji Hye Yoon
COSMAX; Global medical research center

Completed

Evaluation of Human Efficacy for Skin Moisturization and Wrinkle Improvement

Dry Skin

Korea, Republic of
Sun Yat-sen University

Not yet recruiting

Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA). (AERESA)

Lung Cancer

China
Duke University
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

Addressing Barriers to Adult Hearing Healthcare

Hearing Loss | Geriatric Disorder

United States
Lumenis Be Ltd.

Completed

Clinical Evaluation of LightSheer Duet 805nm HS Handpiece

Hair Removal

United States
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia (HS-25-C-01)

Primary Hypercholesterolemia
University of Leipzig

Completed

Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity

Non-cardiac Disease

Germany
University of Edinburgh

Completed

Switching From Cardiac Troponin I to T (TWITCH-ED)

Heart Failure | Myocardial Injury | Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction | Acute Myocardial Ischemia

United Kingdom
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations

Non-small Cell Lung Cancer

China
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Hutchinson Study of High School Smoking

Smoking Cessation

United States
General Hospital of Ningxia Medical University

Unknown

HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell Lung

China
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Capricor Inc.

Completed

Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) (HOPE-OLE)

Duchenne Muscular Dystrophy

United States
Capricor Inc.

Completed

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) (HOPE)

Duchenne Muscular Dystrophy | Cardiomyopathy

United States
Hansoh BioMedical R&D Company

Recruiting

HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer

HR+/HER2- Advanced and/or Metastatic Breast Cancer
Hansoh BioMedical R&D Company

Withdrawn

ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer (ES-SCLC)
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis

Cystic Fibrosis

United States
Hansoh BioMedical R&D Company

Recruiting

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Focal Segmental Glomerulosclerosis | IgA Nephropathy

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Ulf Ekelund
Lund University; Region Skane

Completed

Effectiveness and Safety of a Clinical Assessment and 0h/1h Troponin Rule-Out Protocol (ESC-TROP)

Myocardial Infarction | Chest Pain | Acute Coronary Syndrome | Unstable Angina

Sweden
Centre hospitalier de l'Université de Montréal...
Ethicon Endo-Surgery; Centre de Recherche du Centre Hospitalier de l'Université...

Completed

Pulmonary Artery Sealing Using the HARMONIC ACE+ Shears(HS) for VATS Lobectomy

Lung Cancer

Canada
Royal Free Hospital NHS Foundation Trust
KCI Europe Holding B.V.

Terminated

Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa (HIDRA)

Hidradenitis Suppurativa

United Kingdom

Search clinical trials for: HS-10502

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations